LoginSignup
Bayer logo

Bayer Stock

StockStock
ISIN: DE000BAY0017
Ticker: BAYN
DE000BAY0017
BAYN

Price

Historical dividends and forecast

All dividend data

Bayer has so far distributed $0.118 in 2024. The next dividend will be paid on 02.05.2025

$2.302

CHART BY

Frequently asked questions

What is Bayer's market capitalization?

The market capitalization of Bayer is $26.71B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for Bayer?

Bayer's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$1.402. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Bayer's stock?

Currently, 24 analysts cover Bayer's stock, with a consensus target price of $36.74. Analyst ratings provide insights into the stock's expected performance.

What is Bayer's revenue over the trailing twelve months?

Over the trailing twelve months, Bayer reported a revenue of $51.25B.

What is the EBITDA for Bayer?

Bayer's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $16.61B. EBITDA measures the company's overall financial performance.

What is the free cash flow of Bayer?

Bayer has a free cash flow of $6.17B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Bayer's stock?

The 5-year beta for Bayer is 1.05. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Bayer have, and what sector and industry does it belong to?

Bayer employs approximately 96,567 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of Bayer's shares?

The free float of Bayer is 982.42M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $26.71B

5Y beta

 1.05

EPS (TTM)

 -$1.402

Free Float

 982.42M

Revenue (TTM)

 $51.25B

EBITDA (TTM)

 $16.61B

Free Cashflow (TTM)

 $6.17B

Pricing

1D span
$26.90$27.29
52W span
$26.71$45.63

Analyst Ratings

The price target is $36.74 and the stock is covered by 24 analysts.

Buy

5

Hold

17

Sell

2

Information

Bayer AG is a German-based life science company. The Company's segments are Crop Science, Pharmaceuticals and Consumer Health. The Crop Science segment focuses on seeds, improved plant traits, chemical and biological crop protection products, digital solutions and customer service for sustainable agriculture. The Pharmaceuticals segment focuses on prescription products, especially for cardiology and women's healthcare and specialty therapeutics focused on the areas of cardiology, oncology, hematology and ophthalmology, as well as gene therapy and others. The Consumer Health segment develops, produces and markets nonprescription over-the-counter medicines for self-medication. Its Consumer Health segment portfolio consists of products in dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories, among others.

96,567

Biotechnology & Drugs

Health Care

Identifier

ISIN

DE000BAY0017

Primary Ticker

BAYN

Knockouts

Join the conversation
Sign upLogin